Key result
Metabolic syndrome and insulin resistance in childhood are driven by lipid deposition in insulin-responsive tissues, inducing systemic inflammation and requiring careful risk stratification.
This review highlights the pathophysiology of metabolic syndrome in children and emphasizes the role of basic clinical evaluation for risk stratification in pediatric obesity.
Answers are grounded in this paper and cite their sources.
Ectopic lipid deposition may drive pediatric insulin resistance; leaves open targeted interventions in metabolic syndrome.
The Metabolic syndrome describes a clustering of typical cardiovascular risk factors. The syndrome is also known as "Insulin Resistance syndrome" as a substantial part of the pathophysiology is driven by resistance to the metabolic effects of insulin. The major cause of insulin resistance in childhood is a typical lipid partitioning pattern characterized by increased deposition of lipids within insulin responsive tissues, such as the liver and skeletal muscle and within the viscera. This lipid deposition pattern is also associated with infiltration of intra-abdominal tissues with cells of the immune system, inducing systemic, low-grade inflammation typically observed in insulin resistant obese children and adolescents. Several clues derived from a careful history and physical examination, along with a basic laboratory workup, provide clues in regards to risk stratification in obese children.
No takes yet. Share an insight, caveat, or question.
Ighbariya et al. (2018) conducted a review in Metabolic syndrome and insulin resistance in children. Metabolic syndrome and insulin resistance in childhood are driven by lipid deposition in insulin-responsive tissues, inducing systemic inflammation and requiring careful risk stratification.
Synapse has enriched 10 related papers. Consider them for comparative context: